Literature DB >> 25446663

Trends in management of pelvic organ prolapse among female Medicare beneficiaries.

Aqsa A Khan1, Karyn S Eilber2, J Quentin Clemens3, Ning Wu4, Chris L Pashos4, Jennifer T Anger5.   

Abstract

OBJECTIVE: In the last decade, many new surgical treatments have been developed to achieve less-invasive approaches to prolapse management. However, limited data exist on how the patterns of care for women with pelvic organ prolapse (POP) may have changed over the last decade, and whether mesh implantation techniques have influenced the type of specific compartment repair performed. We used a national data set to analyze the temporal trends in patterns of care for women with POP. STUDY
DESIGN: Data were obtained from Public Use Files from the Centers for Medicare and Medicaid Services for a 5% random sample of national beneficiaries with an International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis of POP from 1999 through 2009. Current Procedural Terminology, 4th Edition and International Classification of Diseases, Ninth Revision, Clinical Modification procedure codes were used to evaluate nonsurgical and surgical management trends for this cohort. Types of surgery were categorized by prolapse compartment and combinations of repairs. After 2005, when applicable codes became available, mesh or graft repairs were also analyzed.
RESULTS: Over the study time period, the number of women with a diagnosis of POP in any 1 year in our 5% sample of Medicare beneficiaries remained relatively stable (range, 21,245-23,268 per year). Rates of pessary insertion were also consistent at 11-13% over the study period. Of the women with a prolapse diagnosis, 14-15% underwent surgical repair, and there was little change over time in surgical management patterns based on compartment. Most commonly, multiple compartments were repaired simultaneously. There was a rapid increase in mesh use such that in 2009, 41% of all women who underwent surgery (5.8% of the total cohort) had mesh or graft inserted in their repair. Hysterectomy rates for prolapse decreased over time. Rates of vault suspension at the time of hysterectomy for prolapse were low; however, they showed a relative increase over time (22% in 1999 to 26% in 2009).
CONCLUSION: Patterns and rates of prolapse repairs remained relatively unchanged from 1999 through 2009, with an exception of a rapid rise in mesh use. These data suggest that the majority of mesh techniques were used for augmentation purposes only, but did not result in an increase in apical repairs performed in the United States. There remains a disappointingly low rate of vault suspension repairs concomitantly at time of hysterectomy for POP.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  epidemiology; mesh; pelvic organ prolapse; trends

Mesh:

Year:  2014        PMID: 25446663      PMCID: PMC5085801          DOI: 10.1016/j.ajog.2014.10.025

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Vaginal hysterectomy for correcting genital prolapse. Long-term evaluation.

Authors:  H R Marana; J M Andrade; R R Marana; M Matheus de Sala; P M Philbert; R Rodrigues
Journal:  J Reprod Med       Date:  1999-06       Impact factor: 0.142

2.  Incidence of pelvic floor repair after hysterectomy: A population-based cohort study.

Authors:  Roberta E Blandon; Adil E Bharucha; L Joseph Melton; Cathy D Schleck; Ebenezer O Babalola; Alan R Zinsmeister; John B Gebhart
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

3.  Risk factors for pelvic organ prolapse repair after hysterectomy.

Authors:  Patrick Dällenbach; Isabelle Kaelin-Gambirasio; Jean-Bernard Dubuisson; Michel Boulvain
Journal:  Obstet Gynecol       Date:  2007-09       Impact factor: 7.661

4.  Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse.

Authors:  Marianna Alperin; Aqsa Khan; Emily Dubina; Christopher Tarnay; Ning Wu; Chris L Pashos; Jennifer T Anger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 May-Jun       Impact factor: 2.091

5.  Trends in use of surgical mesh for pelvic organ prolapse.

Authors:  Michele Jonsson Funk; Autumn L Edenfield; Virginia Pate; Anthony G Visco; Alison C Weidner; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

6.  Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.

Authors:  Jennifer M Wu; Andrew F Hundley; Rebekah G Fulton; Evan R Myers
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

7.  Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence.

Authors:  M F Fialkow; K M Newton; G M Lentz; N S Weiss
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-26

8.  Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries.

Authors:  W Stuart Reynolds; Karen P Gold; Shenghua Ni; Melissa R Kaufman; Roger R Dmochowski; David F Penson
Journal:  Neurourol Urodyn       Date:  2012-09-21       Impact factor: 2.696

9.  Prevalence of symptomatic pelvic floor disorders in US women.

Authors:  Ingrid Nygaard; Matthew D Barber; Kathryn L Burgio; Kimberly Kenton; Susan Meikle; Joseph Schaffer; Cathie Spino; William E Whitehead; Jennifer Wu; Debra J Brody
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

10.  The age distribution, rates, and types of surgery for pelvic organ prolapse in the USA.

Authors:  Aparna D Shah; Neeraj Kohli; Sujatha S Rajan; Lennox Hoyte
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-20
View more
  12 in total

1.  Rate of Pelvic Organ Prolapse Surgery Among Privately Insured Women in the United States, 2010-2013.

Authors:  Anne G Sammarco; Carolyn W Swenson; Neil S Kamdar; Emily K Kobernik; John O L DeLancey; Brahmajee Nallamothu; Daniel M Morgan
Journal:  Obstet Gynecol       Date:  2018-03       Impact factor: 7.661

2.  Total colpocleisis: technical considerations.

Authors:  Brian J Linder; John B Gebhart; John A Occhino
Journal:  Int Urogynecol J       Date:  2016-05-14       Impact factor: 2.894

3.  Procedure Choice in Primary Versus Recurrent Prolapse: A Study of Fellowship-Trained Surgeons.

Authors:  Rachel High; Alex Kavanagh; Rose Khavari; Julie Stewart; Danielle D Antosh
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Jul/Aug       Impact factor: 2.091

4.  Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women.

Authors:  Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson; Emily K Kobernik; Anne G Sammarco; Brahmajee Nallamothu
Journal:  Am J Obstet Gynecol       Date:  2017-12-26       Impact factor: 8.661

5.  Anatomical outcomes 1 year after pelvic organ prolapse surgery in patients with and without a uterus at a high risk of recurrence: a randomised controlled trial comparing laparoscopic sacrocolpopexy/cervicopexy and anterior vaginal mesh.

Authors:  Eduardo Bataller; Cristina Ros; Sonia Anglès; Miriam Gallego; Montserrat Espuña-Pons; Francisco Carmona
Journal:  Int Urogynecol J       Date:  2018-07-09       Impact factor: 2.894

6.  Surgical trends and patient factors associated with the treatment of apical pelvic organ prolapse from a national sample.

Authors:  Emily A Slopnick; Andrey Petrikovets; David Sheyn; Simon P Kim; Carvell T Nguyen; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2018-10-03       Impact factor: 2.894

Review 7.  Epidemiological trends and future care needs for pelvic floor disorders.

Authors:  Alexis A Dieter; Maggie F Wilkins; Jennifer M Wu
Journal:  Curr Opin Obstet Gynecol       Date:  2015-10       Impact factor: 1.927

8.  Documenting pessary offer prior to hysterectomy for management of pelvic organ prolapse.

Authors:  Anne G Sammarco; Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson
Journal:  Int Urogynecol J       Date:  2018-06-22       Impact factor: 2.894

9.  Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort study.

Authors:  Bilal Chughtai; Jialin Mao; Jessica Buck; Steven Kaplan; Art Sedrakyan
Journal:  BMJ       Date:  2015-06-02

10.  Correlations between Mitofusin 2 Expression in Fibroblasts and Pelvic Organ Prolapse: An In vitro Study.

Authors:  Ye Lu; Hua-Yun Chen; Xiao-Qing Wang; Jing-Xue Wang
Journal:  Chin Med J (Engl)       Date:  2017-12-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.